These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37650031)

  • 1. Laying the foundation for Real-world evidence studies: a case study from Newfoundland and Labrador.
    Badaiki W; Pyper E; Lester K; Skeard J; Penney M; Shin J; Fisher B; Hew H; Gulliver S; Gulliver W; Rahman P
    Int J Popul Data Sci; 2022; 7(1):1690. PubMed ID: 37650031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real World Studies of Psoriasis and Mental Illness in Newfoundland and Labrador.
    Badaiki W; Penney M; Pyper E; Lester K; Skeard J; Shin J; Fisher B; Gulliver S; Gulliver W; Rahman P
    J Cutan Med Surg; 2022; 26(5):494-501. PubMed ID: 35938546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Newfoundland and Labrador Bariatric Surgery Cohort Study: Rational and Study Protocol.
    Twells LK; Gregory DM; Midodzi WK; Dillon C; Kovacs CS; MacDonald D; Lester KK; Pace D; Smith C; Boone D; Murphy R
    BMC Health Serv Res; 2016 Oct; 16(1):618. PubMed ID: 27793212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of real-world evidence for oncology clinical decision making in emerging economies.
    Petracci F; Ghai C; Pangilinan A; Suarez LA; Uehara R; Ghosn M
    Future Oncol; 2021 Aug; 17(22):2951-2960. PubMed ID: 34044583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-terrain vehicle-related injuries and deaths in Newfoundland and Labrador between 2003 and 2013: a retrospective trauma registry review.
    Black H; Whalen D; Alani S; Rogers P; MacLean C
    CJEM; 2018 Mar; 20(2):207-215. PubMed ID: 28693640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Economic Impact of Healthcare Innovation Activity on the Newfoundland and Labrador Economy in 2019 and 2020.
    Doyle M
    Healthc Q; 2022 Jan; 24(4):16-21. PubMed ID: 35216644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicide in Newfoundland and Labrador, Canada: a time trend analysis from 1981 to 2018.
    Pollock NJ; Liu L; Wilson MM; Reccord C; Power ND; Mulay S; Karaivanov Y; Tonmyr L
    BMC Public Health; 2021 Jul; 21(1):1291. PubMed ID: 34215242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of severe burn among children in Newfoundland and Labrador, Canada.
    Alaghehbandan R; Sikdar KC; Gladney N; MacDonald D; Collins KD
    Burns; 2012 Feb; 38(1):136-40. PubMed ID: 22103990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of prevalence of biologic use and discontinuation rates in moderate-to-severe psoriasis patients in Newfoundland and Labrador using real-world data.
    Gulliver SR; Gulliver W
    Dermatol Ther; 2021 May; 34(3):e14944. PubMed ID: 33719143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adults with diabetes mellitus in Newfoundland and Labrador: a population-based, cross-sectional analysis.
    Lukewich J; Buote R; Asghari S; Aubrey-Bassler K; Knight J; Mathews M
    CMAJ Open; 2020; 8(4):E895-E901. PubMed ID: 33355275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognosis and comorbidities associated with psoriasis in the Newfoundland and Labrador founder population.
    Gulliver WP; Macdonald D; Gladney N; Alaghehbandan R; Rahman P; Adam Baker K
    J Cutan Med Surg; 2011; 15(1):37-47. PubMed ID: 21291654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
    Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
    F1000Res; 2018; 7():111. PubMed ID: 30026923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a mixed-methods study on barriers to physician recruitment in Newfoundland and Labrador.
    Kidd M; Fairbridge N; O'Keefe A; Farrell G
    Can J Rural Med; 2023; 28(3):116-122. PubMed ID: 37417042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
    Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
    Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery bypass graft surgery in Newfoundland and Labrador.
    Fox GA; O'Dea J; Parfrey PS
    CMAJ; 1998 May; 158(9):1137-42. PubMed ID: 9597964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.
    Chan K; Nam S; Evans B; de Oliveira C; Chambers A; Gavura S; Hoch J; Mercer RE; Dai WF; Beca J; Tadrous M; Isaranuwatchai W
    BMJ Open; 2020 Jan; 10(1):e032884. PubMed ID: 31915169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The geospatial relation between UV solar radiation and type 1 diabetes in Newfoundland.
    Sloka S; Grant M; Newhook LA
    Acta Diabetol; 2010 Mar; 47(1):73-8. PubMed ID: 19238314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute diabetes complications across transition from pediatric to adult care in Ontario and Newfoundland and Labrador: a population-based cohort study.
    Shulman R; Fu L; Knight JC; Guttmann A; Chafe R
    CMAJ Open; 2020; 8(1):E69-E74. PubMed ID: 32046971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiative.
    Orsini LS; Monz B; Mullins CD; Van Brunt D; Daniel G; Eichler HG; Graff J; Guerino J; Berger M; Lederer NM; Jonsson P; Schneeweiss S; Wang SV; Crown W; Goettsch W; Willke RJ
    Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1504-1513. PubMed ID: 32924243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making.
    Chen S; Graff J; Yun S; Beal B; Ta JT; Bansal A; Carlson JJ; Veenstra DL; Basu A; Devine B
    J Manag Care Spec Pharm; 2021 Jan; 27(1):95-104. PubMed ID: 33377442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.